Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Bluejay Diagnostics (BJDX) EPS (Weighted Average and Diluted) (2022 - 2023)

Bluejay Diagnostics' EPS (Weighted Average and Diluted) history spans 2 years, with the latest figure at -$3573.1 for Q4 2023.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 146719.67% to -$3573.1 in Q4 2023 year-over-year; TTM through Dec 2023 was -$3761.8, a 154475.26% decrease, with the full-year FY2025 number at -$15.25, up 96.66% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$3573.1 in Q4 2023 for Bluejay Diagnostics, down from -$16.67 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for BJDX hit a ceiling of -$0.1 in Q1 2022 and a floor of -$3573.1 in Q4 2023.